Application note: Miniaturizing immunoassays for improved performance (Gyros)
Assay development in conventional immunoassay formats, such as ELISA, is a time- and reagent-consuming process due to long assay times and limited flexibility in experimental set-up. Resulting immunoassays typically exhibit good overall performance, but may have limitations in terms of measurement range and matrix compatibility.
The automated, miniaturized assay format of the Gyros™ immunoassay platform enables fast, flexible assay development. Working at nanoliter scale reduces consumption of sample and reagents up to one hundred fold when compared to ELISA.
